Dyesol partnership sets world record with PSC technology

Published 10-MAR-2017 16:33 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Shares in Dyesol (ASX: DYE) hit a high of 23 cents on Friday morning, only about 10% shy of the company’s 12 month high after the group announced that one of its partners, Solliance, had achieved a world record for perovskite solar cell photovoltaic (PSC PV) technology demonstrated on industrially applicable Roll to Roll (R2R) processes of 12.6% conversion efficiency at cell level.

While the underlying nature of these achievements are highly technical, and DYE’s operations involve relatively complex technology, in essence the group is a global leader in the development and commercialisation of PSC technology.

This technology is based on applying low-cost materials in a series of ultra-thin layers encapsulated by protective sealants. DYE’s technology has demonstrated lower embodied energy in manufacture, produces stable electrical current, and has a strong competitive advantage in low light conditions relative to incumbent PV technologies.

Central to the company’s strategy is the development of a range of products that use and leverage off its PSC materials, NexGen technology and PV panels.

The Solliance partnership

Solliance is one of a number of DYE’s high profile partners which include leading innovative Australian and international technology developers such as CSIRO, Tata Steel and Nanyang Technological University.

Solliance is a cross-border Dutch-Flemish-German thin-film photovoltaics research initiative conducting advanced research on the development of perovskite-based PV modules and its applications with its industrial partners Solartek, Dyesol and Panasonic.

With these results the Solliance partners have demonstrated the effectiveness of their collaboration in the development of perovskite based PV modules.

In commenting on this latest development, DYE’s Managing Director Richard Caldwell said, “Dyesol is very pleased with this breakthrough, as we are committed to developing the industry standard for R2R Perovskite Solar Cell (PSC) PV manufacturing in conjunction with Solliance, and this result is an important step along this route”.

Dyesol and partners maintain global leadership position

Caldwell highlighted that the pioneering work confirmed Dyesol and its partners retained a global leadership position in the industrialisation of PSC Technology, and in particular, its continuous R2R processing for flexible BIPV applications – a core element of its commercialisation strategy.

Putting the achievement of this record into perspective, Mr Caldwell explained that a small, lab scale perovskite-based PV cell is 22,1%. He said the challenge is to upscale perovskite cells to larger size, industrially-manufacturable modules with high efficiency and long lifetime at low cost.

He sees these 12,6% R2R up-scaled perovskite-based solar cells as a first and important step in this development, providing confidence that the group can quickly boost the upscaled perovskite based PV module efficiency above 15% by using low cost materials and processes.

Commenting on some of the technical features, Program Director at Solliance, Ronn Andriessen said, “Thanks to its high power conversion efficiency and flexible and light-weight nature, thin-film perovskite PV technology is widely considered as a future key technology for the building-integrated photovoltaics (BIPV) market.

He highlighted that it can be seamlessly integrated in building elements, on curved surfaces and can be made semi-transparent. Combining the industrially-applicable manufacturing processes with Solliance’s proprietary back-end interconnection process allows the creation of perovskite-based PV modules with any form and shape and any desired current-voltage output, potentially enabling customized and aesthetic integration of solar modules for infrastructure, building and vehicle-integrated PV products.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X